| NCT06539481 | Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye. | RECRUITING | PHASE4 | 2024-08-31 | 2028-10-31 | 2026-07-15 |
| NCT05322070 | Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis | ACTIVE_NOT_RECRUITING | PHASE4 | 2022-06-06 | 2025-11 | 2025-11 |
| NCT04469595 | A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME) | ACTIVE_NOT_RECRUITING | PHASE4 | 2020-08-31 | 2024-12-31 | 2024-12-31 |
| NCT02424019 | Phase 4 IOP Signals Associated With ILUVIEN® | COMPLETED | PHASE4 | 2015-05-06 | 2020-07-31 | 2020-07-29 |
| NCT02472366 | A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy | COMPLETED | PHASE4 | 2014-01 | 2015-05 | 2015-03 |
| NCT01304706 | Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study | COMPLETED | PHASE3 | 2011-04 | | 2013-11 |
| NCT00770770 | Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina | TERMINATED | PHASE2 | 2009-05 | | 2013-10 |
| NCT00695318 | Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy | TERMINATED | PHASE2 | 2008-12 | | 2013-10 |
| NCT00344968 | Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema | COMPLETED | PHASE3 | 2007-09 | 2010-12 | 2009-12 |
| NCT00490815 | Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema | COMPLETED | PHASE3 | 2007-08 | 2011-04 | 2009-09 |